New Delhi: Following a crackdown on 156 fixed dose combination (FDC) drugs after finding them without therapeutic justification and even unsafe in several cases, a top official in the Central Drugs Standard Control …
New Delhi: India’s apex drug regulator has given conditional approval to continue the manufacture and sale of five fixed-dose combination (FDC) medicines, asking drugmakers to produce post-marketing safety and efficacy data …
NEW DELHI: After four consecutive months of uptrend, Nifty bulls are displaying signs of exhaustion as we enter the August derivative expiry series. “The August series has been favorable for …